DOI: 10.3201/eid2501.180352; PMCID: PMC6302606
© 2018, Centers for Disease Control and Prevention (CDC). All rights reserved. Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neutralizing antibody prevalence across all regions and time periods, indicating widespread circulation.
Emerging Infectious Diseases
Australia; Picornaviruses; United States; neutralizing antibody; outbreak; parechovirus A3; seroepidemiology; seroprevalence; the Netherlands; viruses.
Karelehto E, Brouwer L, Benschop K, et al. Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States. Emerg Infect Dis. 2019;25(1):148-152. doi:10.3201/eid2501.180352